MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by COULTER, A. W.
Right arrow Articles by TALALAY, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by COULTER, A. W.
Right arrow Articles by TALALAY, P.

Molecular Pharmacology, Vol 10, 293-304, Copyright © 1974 by the American Society for Pharmacology and Experimental Therapeutics

Structural and Conformational Analogues of L-Methionine as Inhibitors of the Enzymatic Synthesis of S-Adenosyl-L-methionine

I. Saturated and Unsaturated Aliphatic Amino Acids

A. W. COULTER 1, J. B. LOMBARDINI 1, and PAUL TALALAY 1

1 Department of Pharmacology and Experimental Therapeutics, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

Aliphatic amino acid analogues of L-methionine that inhibit the enzymatic synthesis of S-adenosyl-L-methionine have been designed onthe basis of structural, conformational, and electronic considerations. The inhibitory activity of these compounds has been evaluated with partially purified preparations of ATP:L-methionine S-adenosyltransferase (EC 2.5.1.6) obtained from bakers’ yeast, Escherichia coli, and rat liver. The effects of variation in length and branching of carbon chain, steric configuration, degree or position of unsaturation, and the introduction of chloro groups have been analyzed in an effort to deduce the most favourable features for inhibition. Within this class of compounds, 2-amino-4-hexynoic acid, (E)-2-amino-trans-4-hexenoic acid, and (Z)-2-amino-5-chloro-trans-4-hexenoic acid are among the most powerful inhibitors synthesized. In contrast, (Z)-2-amino-cis-4-hexenoic acid and (E)-2-amino-5-chloro-cis-4-hexenoic acid are weak inhibitors or are inactive. The activity of the more powerful inhibitors appears to reside exclusively in the L isomers. (Z)-L-2-Amino-5-chloro-trans-4-hexenoic acid displays considerably greater specificity for the inhibition of rat liver enzyme (I50 = 0.55 mM) than for the yeast (I50 = 3.0 mM) or E. coli (I50 = 4.2 mM) adenosyltransferase. Examination of molecular models reveals a close similarity in the size, shape, and molecular contour between an extended conformation of L-methionine and L-2-amino-4-hexynoic acid and (Z)-L-2-amino-5-chloro-trans-4-hexenoic acid. Another compound with significant inhibitory activity is (2S, 4S)-2-amino-4,5-methylene-5-hexenoic acid (hypoglycin A).

Note:
ACKNOWLEDGMENTS The authors are grateful to Mrs. Mary Karen Burch, Mrs. JoAnn Kaufmann, Mrs. Patricia M. Margulies, and Mrs. Jean Salt for skillful assistance in various aspects of these studies. Valuable gifts of various compounds are acknowledged in the text. We are also grateful to our colleague, Dr. C. H. Robinson, for much valuable advice.

Submitted on August 20, 1973




This article has been cited by other articles:


Home page
J. Nutr.Home page
N. Ubeda, E. Alonso-Aperte, and G. Varela-Moreiras
Acute Valproate Administration Impairs Methionine Metabolism in Rats
J. Nutr., September 1, 2002; 132(9): 2737 - 2742.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1974 by the American Society for Pharmacology and Experimental Therapeutics